Cargando…

Lipoprotein-Associated Phospholipase A2 Activity Predicts Cardiovascular Events in High Risk Coronary Artery Disease Patients

OBJECTIVE: Lipoprotein-associated phospholipase A2 (Lp-PLA2) is deemed to play a role in atherosclerosis and plaque destabilization as demonstrated in animal models and in prospective clinical studies. However, most of the literature is either focused on high-risk, apparently healthy patients, or is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maiolino, Giuseppe, Pedon, Luigi, Cesari, Maurizio, Frigo, Anna Chiara, Wolfert, Robert L., Barisa, Marlena, Pagliani, Leopoldo, Rossitto, Giacomo, Seccia, Teresa Maria, Zanchetta, Mario, Rossi, Gian Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485195/ https://www.ncbi.nlm.nih.gov/pubmed/23118945 http://dx.doi.org/10.1371/journal.pone.0048171

Ejemplares similares

Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension
por: Rossi, Gian Paolo, et al.
Publicado: (2020)

The Role of Oxidized Low-Density Lipoproteins in Atherosclerosis: The Myths and the Facts
por: Maiolino, Giuseppe, et al.
Publicado: (2013)

Oral Burning With Dysphagia and Weight Loss
por: Seccia, Teresa Maria, et al.
Publicado: (2015)

Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk
por: Colley, Kenneth J., et al.
Publicado: (2011)

Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study
por: Katan, Mira, et al.
Publicado: (2014)

High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension
por: Rossitto, Giacomo, et al.
Publicado: (2020)

Lipoprotein-Associated Phospholipase A(2) Mass and Activity and Risk of Cardiovascular Disease in a Population With High Prevalences of Obesity and Diabetes: The Strong Heart Study
por: Kizer, Jorge R., et al.
Publicado: (2012)

Coronary sinus diameter to estimate congestion and predict survival
por: Barchitta, Agatella, et al.
Publicado: (2023)

Lipoprotein‐associated phospholipase A2: The story continues
por: Huang, Fubao, et al.
Publicado: (2019)

Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events
por: Siddiqui, Moneeza K., et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
por: Doody, Rachelle S., et al.
Publicado: (2015)

A systematic review of pathophysiology and management of familial hyperaldosteronism type 1 in pregnancy
por: Sanga, Viola, et al.
Publicado: (2021)

Urinary sodium potassium ratio is associated with clinical success after adrenalectomy in patients with unilateral primary aldosteronism
por: Zhu, Rui, et al.
Publicado: (2021)

Racial variation in lipoprotein-associated phospholipase A(2 )in older adults
por: Lee, Keane K, et al.
Publicado: (2011)

Secreted phospholipase A(2), lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics
por: Yamamoto, Kei, et al.
Publicado: (2011)

Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
por: Wang, Yuan, et al.
Publicado: (2022)

The Key Role of Epithelial to Mesenchymal Transition (EMT) in Hypertensive Kidney Disease
por: Seccia, Teresa, et al.
Publicado: (2019)

Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification
por: Cesari, Maurizio, et al.
Publicado: (2021)

The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism
por: Rossi, Gian Paolo, et al.
Publicado: (2020)

Usefulness of computed tomography in rare cardiac anomalies: association between suprapulmonary ring and Ebstein’s disease of tricuspid valve
por: Zecchel, Roberto, et al.
Publicado: (2019)

Lipoprotein-Associated Phospholipase A(2), Vascular Inflammation and Cardiovascular Risk Prediction
por: Sudhir, Krishnankutty
Publicado: (2006)

Is lipoprotein-associated phospholipase A(2) correlated with cardiovascular risk in European women?
por: Hirschler, V.
Publicado: (2013)

Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories
por: Dhamoon, Mandip S., et al.
Publicado: (2019)

The correlation between lipoprotein associated phospholipase A(2) and central overweight status
por: Chen, Yi-Hsuan, et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A(2): A paradigm for allosteric regulation by membranes
por: Mouchlis, Varnavas D., et al.
Publicado: (2022)

Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia
por: Zuliani, Giovanni, et al.
Publicado: (2023)

The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy
por: Zhai, Yan, et al.
Publicado: (2023)

Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study
por: Maiolino, Giuseppe, et al.
Publicado: (2017)

Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China
por: Huang, Yuli, et al.
Publicado: (2017)

Elevated lipoprotein(a) and lipoprotein-associated phospholipase A(2) are associated with unfavorable functional outcomes in patients with ischemic stroke
por: Jiang, Xue, et al.
Publicado: (2021)

Active site competition is the mechanism for the inhibition of lipoprotein-associated phospholipase A(2) by detergent micelles or lipoproteins and for the efficacy reduction of darapladib
por: Zhuo, Shaoqiu, et al.
Publicado: (2020)

Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
por: Gong, Hui-ping, et al.
Publicado: (2011)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Ambient Air Pollution and Lipoprotein-Associated Phospholipase A(2) in Survivors of Myocardial Infarction
por: Brüske, Irene, et al.
Publicado: (2011)

Evaluation of lipoprotein-associated Phospholipase A2 in Healthy Chinese Han Adult Serum
por: Feng, Li-Min, et al.
Publicado: (2014)

Correlation between plasma lipoprotein-associated phospholipase A(2) and peripheral arterial disease
por: LI, SHUAI-BING, et al.
Publicado: (2013)

The Role of Lipoprotein-Associated Phospholipase A₂ in a Murine Model of Experimental Autoimmune Uveoretinitis
por: Crawford, G. L., et al.
Publicado: (2015)

Association of lipoprotein‐associated phospholipase A2 mass with asymptomatic cerebral artery stenosis
por: Wang, Youxin, et al.
Publicado: (2018)

The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease
por: Zhang, Hao, et al.
Publicado: (2020)

The role of lipoprotein-associated phospholipase A2 in acute kidney injury of septic mice
por: Liang, Guiwen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kt52he2f8iaq0ndduol17s3gmg